Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.1K Sell
1,127
-168
-13% -$4.39K 0.01% 100
2026
Q1
$36.4K Sell
1,295
-17
-1% -$453 0.02% 88
2025
Q4
$32.7K Buy
1,312
+353
+37% +$8.9K 0.01% 90
2025
Q3
$24.4K Buy
959
+50
+6% +$1.23K 0.01% 101
2025
Q2
$22K Hold
909
0.01% 99
2025
Q1
$23K Hold
909
0.01% 92
2024
Q4
$24.1K Buy
909
+188
+26% +$5.1K 0.01% 93
2024
Q3
$20.9K Sell
721
-293
-29% -$8.55K 0.01% 94
2024
Q2
$28.4K Sell
1,014
-149
-13% -$4.1K 0.02% 89
2024
Q1
$32.3K Hold
1,163
0.02% 85
2023
Q4
$33.5K Hold
1,163
0.02% 80
2023
Q3
$38.6K Sell
1,163
-374
-24% -$13.2K 0.03% 83
2023
Q2
$56.4K Buy
1,537
+500
+48% +$19.5K 0.04% 72
2023
Q1
$42.3K Sell
1,037
-46
-4% -$1.99K 0.03% 77
2022
Q4
$55.5K Sell
1,083
-18,502
-94% -$887K 0.04% 67
2022
Q3
$857K Sell
19,585
-52,808
-73% -$2.57M 0.7% 48
2022
Q2
$3.8M Sell
72,393
-156
-0.2% -$7.95K 3.96% 3
2022
Q1
$3.76M Buy
+72,549
New +$3.76M 2.83% 10
2021
Q4
Sell
-98,108
Closed -$4.22M 202
2021
Q3
$4.22M Buy
98,108
+5,900
+6% +$261K 3.11% 5
2021
Q2
$3.61M Buy
+92,208
New +$3.59M 4.07% 9
2021
Q1
Sell
-122,645
Closed -$4.51M 198
2020
Q4
$4.51M Buy
+122,645
New +$4.5M 4.45% 3

Other funds holding PFE

Robbins Farley's PFE Position: Q2 2026 in Review

Robbins Farley reduced its Pfizer (PFE) stake by 13% in Q2 2026, selling an estimated $4.39K and leaving 1,127 shares worth $27.1K. The position accounts for 0.01% of the portfolio, ranked #100.

Robbins Farley first reported a position in PFE in Q4 2020 and has held it in 21 quarters since. The position peaked at $4.51M in Q4 2020. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Robbins Farley held 1,127 shares of Pfizer worth $27.1K as of Q2 2026.
  • Robbins Farley sold 168 Pfizer shares in Q2 2026, an estimated $4.39K.
  • Pfizer made up 0.01% of Robbins Farley's portfolio in Q2 2026, its #100 holding.
  • Robbins Farley first reported a position in Pfizer in Q4 2020 and has held it in 21 quarters since.
  • Robbins Farley's Pfizer position peaked at $4.51M in Q4 2020.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Robbins Farley's 13F filing for Q2 2026, filed 23 Jul 2026.